Protagonist Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. 

CEO
Dinesh V. Patel
CEODinesh V. Patel
Employees
126
Employees126
Headquarters
Newark, California
HeadquartersNewark, California
Founded
2006
Founded2006
Employees
126
Employees126

PTGX Key Statistics

Market cap
3.37B
Market cap3.37B
Price-Earnings ratio
12.95
Price-Earnings ratio12.95
Dividend yield
Dividend yield
Average volume
2.09M
Average volume2.09M
High today
$56.55
High today$56.55
Low today
$53.53
Low today$53.53
Open price
$55.34
Open price$55.34
Volume
1.20M
Volume1.20M
52 Week high
$60.60
52 Week high$60.60
52 Week low
$24.22
52 Week low$24.22

PTGX News

Simply Wall St 6d
Protagonist Therapeutics, Inc.'s Shares Climb 44% But Its Business Is Yet to Catch Up

Protagonist Therapeutics, Inc. ( ) shares have had a really impressive month, gaining 44% after a shaky period beforehand. Looking back a bit further, it's enco...

Protagonist Therapeutics, Inc.'s Shares Climb 44% But Its Business Is Yet to Catch Up

Analyst ratings

91%

of 11 ratings
Buy
90.9%
Hold
9.1%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.